Related Experiment Video
Updated: Feb 8, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
CIDEC Is Involved in LPS-Induced Inflammation and Apoptosis in Renal Tubular Epithelial Cells
Jin He1, Bin Zhang2, Hua Gan3,4
1Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Abstract:
Adenosine 5'-monophosphate-activated protein kinase (AMPK) has been shown to have anti-inflammatory effect by inhibition of the nuclear factor κB (NF-κB) pathway and is involved in lipopolysaccharide (LPS)-induced inflammation. Cell-death-inducing DFF45-like effector C (CIDEC) can directly down-regulate AMPK activity through interacting with AMPKα subunit. However, whether the AMPK or CIDEC is involved in LPS-induced inflammation in renal tubular epithelial cells is still unknown. Therefore, we studied the role of AMPK and CIDEC in LPS-treated NRK-52E cells. Our results showed that LPS could up-regulate the expression of CIDEC in vitro and in vivo. Silencing CIDEC by CIDEC-siRNA could restore expression of phosphorylated-AMPKα which was decreased by LPS, suppress LPS-induced NF-κB pathway activation, and TNF-α, IL-6, and IL-1β production in NRK-52E cells. Furthermore, silencing CIDEC also partially alleviated LPS-induced epithelial cells apoptosis. In conclusion, the results demonstrated that CIDEC/AMPK signaling pathway played an important role in LPS-induced inflammation and epithelial cells apoptosis.
Insights
Cell-death-inducing DFF45-like effector C (CIDEC) promotes kidney inflammation by inhibiting Adenosine 5'-monophosphate-activated protein kinase (AMPK). Silencing CIDEC reduces inflammation and apoptosis in renal cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Immunology
Background:
- Adenosine 5'-monophosphate-activated protein kinase (AMPK) exhibits anti-inflammatory properties via Nuclear Factor-kappa B (NF-κB) pathway inhibition.
- Lipopolysaccharide (LPS) induces inflammation, and Cell-death-inducing DFF45-like effector C (CIDEC) negatively regulates AMPK activity.
Purpose of the Study:
- To investigate the roles of AMPK and CIDEC in LPS-induced inflammation in renal tubular epithelial cells (NRK-52E).
- To elucidate the CIDEC/AMPK signaling pathway's involvement in renal inflammation and apoptosis.
Main Methods:
- LPS treatment of NRK-52E cells in vitro and in vivo.
- CIDEC silencing using CIDEC-siRNA.
- Analysis of phosphorylated-AMPKα expression, NF-κB pathway activation, pro-inflammatory cytokine production (TNF-α, IL-6, IL-1β), and apoptosis.
Main Results:
- LPS upregulated CIDEC expression in renal tubular epithelial cells.
- CIDEC silencing restored LPS-impaired AMPK activity.
- Silencing CIDEC suppressed LPS-induced NF-κB activation, pro-inflammatory cytokine release, and partially alleviated apoptosis.
Conclusions:
- CIDEC plays a critical role in mediating LPS-induced inflammation and apoptosis in renal tubular epithelial cells.
- The CIDEC/AMPK signaling pathway is a key regulator of renal inflammation and cell death in response to LPS.
Related Concept Videos
Renal Drug Excretion: Tubular Reabsorption
Renal Drug Excretion: Tubular Secretion
Drug Elimination by Renal Route: Tubular Secretion
Drug Elimination by Renal Route: Tubular Reabsorption
Inflammation
Apoptosis

